Literature DB >> 88781

Antisera reactive directly to estrone sulfate.

R I Cox, R M Hoskinson, M S Wong.   

Abstract

Derivatives of estrone were prepared and linked to bovine serum albumin or its methyl-esterified form to produce immunogens which were effective in raising antisera to estrone sulfate. The most effective was estrone-3-methylphosphonothioate, electrostatically complexed with methylated bovine serum albumin. The ionically combined hapten functioned as an antigenic determinant as do covalently bound haptens when administered to sheep in emulsions with Freund's complete adjuvant. Estrone-3-phosphate covalently or electrostatically linked to bovine serum albumin also produced antisera reactive to estrone sulfate. Estrone sulfate itself, after electrostatically complexing to methylated bovine serum albumin and administration with Freund's complete adjuvant to sheep, was ineffective in producing antisera. The sera which had workable titres to estrone sulfate showed considerable cross-reaction with free estrone but was otherwise highly specific with little or no reaction with other steroid sulfates, glucosiduronates or other free steroids. Radioimmunoassay curves using [6,7-3H]-estrone sulfate were highly sensitive and were effective in the range of 5-250 pg estrone sulfate.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 88781     DOI: 10.1016/0039-128x(79)90035-7

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  3 in total

1.  Pregnancy diagnosis in Swine: a comparison of two ultrasound instruments.

Authors:  G W Almond; W T Bosu; G J King
Journal:  Can Vet J       Date:  1985-07       Impact factor: 1.008

2.  Estrogens from sewage in coastal marine environments.

Authors:  Shannon Atkinson; Marlin J Atkinson; Ann M Tarrant
Journal:  Environ Health Perspect       Date:  2003-04       Impact factor: 9.031

3.  Immunofluorescent detection of hormone receptors in cutaneous melanocytic tumours.

Authors:  A J Thompson; M G Cook; P G Gill
Journal:  Br J Cancer       Date:  1981-05       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.